» Articles » PMID: 37322044

Focused Ultrasound Thalamotomy for Tremor Treatment Impacts the Cerebello-thalamo-cortical Network

Overview
Date 2023 Jun 15
PMID 37322044
Authors
Affiliations
Soon will be listed here.
Abstract

High-intensity Magnetic Resonance-guided Focused Ultrasound (MRgFUS) is a recent, non-invasive line of treatment for medication-resistant tremor. We used MRgFUS to produce small lesions in the thalamic ventral intermediate nucleus (VIM), an important node in the cerebello-thalamo-cortical tremor network, in 13 patients with tremor-dominant Parkinson's disease or essential tremor. Significant tremor alleviation in the target hand ensued (t(12) = 7.21, p < 0.001, two-tailed), which was strongly associated with the functional reorganization of the brain's hand region with the cerebellum (r = 0.91, p < 0.001, one-tailed). This reorganization potentially reflected a process of normalization, as there was a trend of increase in similarity between the hand cerebellar connectivity of the patients and that of a matched, healthy control group (n = 48) after treatment. Control regions in the ventral attention, dorsal attention, default, and frontoparietal networks, in comparison, exhibited no association with tremor alleviation and no normalization. More broadly, changes in functional connectivity were observed in regions belonging to the motor, limbic, visual, and dorsal attention networks, largely overlapping with regions connected to the lesion targets. Our results indicate that MRgFUS is a highly efficient treatment for tremor, and that lesioning the VIM may result in the reorganization of the cerebello-thalamo-cortical tremor network.

Citing Articles

Early re-emerging tremor after MRgFUS thalamotomy: case-control analysis of procedural and imaging features.

Bruno F, Badini P, Innocenzi A, Saporito G, Catalucci A, Sucapane P Front Neurol. 2024; 15:1356613.

PMID: 38903176 PMC: 11187326. DOI: 10.3389/fneur.2024.1356613.


Individualized functional connectivity markers associated with motor and mood symptoms of Parkinson's disease.

Dahmani L, Bai Y, Zhang W, Ren J, Li S, Hu Q bioRxiv. 2024; .

PMID: 38352322 PMC: 10862849. DOI: 10.1101/2024.01.31.578238.


Efficacy and safety of magnetic resonance-guided focused ultrasound for Parkinson's disease: a systematic review and meta-analysis.

Tian X, Hu R, He P, Ye J Front Neurol. 2023; 14:1301240.

PMID: 38146437 PMC: 10749343. DOI: 10.3389/fneur.2023.1301240.

References
1.
Gallay M, Moser D, Magara A, Haufler F, Jeanmonod D . Bilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson's Disease With 1-Year Follow-Up. Front Neurol. 2021; 12:601153. PMC: 7900542. DOI: 10.3389/fneur.2021.601153. View

2.
Krishna V, Sammartino F, Cosgrove R, Ghanouni P, Schwartz M, Gwinn R . Predictors of Outcomes After Focused Ultrasound Thalamotomy. Neurosurgery. 2019; 87(2):229-237. DOI: 10.1093/neuros/nyz417. View

3.
Meng Y, Hynynen K, Lipsman N . Applications of focused ultrasound in the brain: from thermoablation to drug delivery. Nat Rev Neurol. 2020; 17(1):7-22. DOI: 10.1038/s41582-020-00418-z. View

4.
Dormont D, Cornu P, Pidoux B, Bonnet A, Biondi A, Oppenheim C . Chronic thalamic stimulation with three-dimensional MR stereotactic guidance. AJNR Am J Neuroradiol. 1997; 18(6):1093-107. PMC: 8337308. View

5.
Fasano A, Llinas M, Munhoz R, Hlasny E, Kucharczyk W, Lozano A . MRI-guided focused ultrasound thalamotomy in non-ET tremor syndromes. Neurology. 2017; 89(8):771-775. DOI: 10.1212/WNL.0000000000004268. View